Why this two-peptide combination is the most popular growth hormone protocol in the research space — and what the science behind it actually says.
CJC-1295 and Ipamorelin are two separate peptides almost always used together. Each one triggers growth hormone release through a different mechanism — and that difference is exactly why they're stacked.
CJC-1295 (without DAC) is a synthetic analog of Growth Hormone Releasing Hormone (GHRH). It signals the pituitary gland to release GH by mimicking the body's own GHRH pulse. It has a short half-life (~30 minutes), which makes it ideal for mimicking the body's natural pulsatile GH release pattern.
Ipamorelin is a Growth Hormone Releasing Peptide (GHRP) — specifically a selective ghrelin receptor agonist. It triggers GH release through a completely different pathway than CJC-1295, and critically, it does so without significantly raising cortisol or prolactin — a key advantage over older GHRPs like GHRP-6 or GHRP-2.
CJC-1295 vs CJC-1295 with DAC: The version used in this stack is CJC-1295 without DAC (Drug Affinity Complex). The DAC version has a much longer half-life (~8 days) which produces a sustained GH elevation rather than a pulse — a different research profile entirely. Most protocols use the no-DAC version specifically for its pulsatile effect.
Using a GHRH and a GHRP together isn't just convenient — it's synergistic. The two compounds amplify each other's GH-releasing effect beyond what either achieves alone.
CJC-1295 activates the GHRH receptor; Ipamorelin activates the ghrelin/GHS receptor. Stimulating both simultaneously produces a significantly larger GH pulse than either alone — research in animal and human models has shown the combination effect is additive to synergistic.
Older GHRPs (GHRP-6, GHRP-2) were effective but raised cortisol and prolactin significantly. Ipamorelin was developed specifically to avoid this — it's highly selective for GH release with minimal effect on other hormones, making it the preferred GHRP pairing.
Unlike synthetic HGH injections which create a sustained supraphysiologic spike, the CJC/Ipa stack triggers pulsatile GH release that mimics the body's own pattern. This is considered a key advantage from a research perspective for maintaining receptor sensitivity and natural feedback loops.
Understanding the mechanism clarifies why timing matters and why this combination is so consistently used in research protocols.
CJC-1295 binds to GHRH receptors on somatotroph cells in the anterior pituitary. This triggers cyclic AMP production and intracellular signaling cascades that result in GH synthesis and release. The no-DAC version is cleared quickly, producing a sharp GH pulse rather than sustained elevation.
Ipamorelin activates the GHS-R1a receptor (the ghrelin receptor) on pituitary somatotrophs. This is a completely separate receptor from the GHRH receptor CJC-1295 targets. GHS-R1a activation amplifies intracellular calcium signaling, which directly drives GH secretion. Ipamorelin's selectivity for this receptor — versus older GHRPs that hit multiple receptor types — is why it doesn't spike cortisol or prolactin.
The combined effect: When both peptides are injected simultaneously, the pituitary receives two independent stimulatory signals at the same time. The result is a GH pulse significantly larger than either peptide produces alone — estimated at 2-10x baseline GH levels in research models depending on dose and timing.
The effects studied with GH secretagogue stacks like CJC/Ipa broadly follow what elevated GH and downstream IGF-1 produce in the body — with the important caveat that most robust data comes from HGH research and GH-deficient populations rather than CJC/Ipa specifically.
| Effect Category | Mechanism | Evidence Level |
|---|---|---|
| Body composition | GH promotes lipolysis (fat breakdown) and lean mass preservation | Strong in GH deficiency models; moderate in healthy subjects |
| Recovery & repair | Elevated IGF-1 downstream of GH accelerates tissue repair | Moderate — consistent with GH research literature |
| Sleep quality | GH is predominantly secreted during deep sleep; stack may amplify nocturnal pulse | Commonly reported in research contexts |
| Skin & collagen | GH and IGF-1 stimulate collagen synthesis and skin thickness | Documented in aging/GH deficiency studies |
| Bone density | IGF-1 promotes osteoblast activity | Strong in GH deficiency; less data in healthy individuals |
Important context: CJC-1295 and Ipamorelin have clinical research of their own — Ipamorelin has been studied in Phase 2 trials for postoperative ileus, and CJC-1295 has been studied in healthy adults. However, the combination stack has less direct clinical trial data than HGH itself. Most effect expectations are extrapolated from GH biology and individual compound research.
CJC-1295 and Ipamorelin are typically available pre-blended at 5mg/5mg per vial, or purchased separately and injected together in the same syringe.
Before bed is the most common injection timing. The body's largest natural GH pulse occurs during the first few hours of deep sleep — injecting 30 minutes before sleep allows the stack to amplify this pulse rather than compete with it.
Some protocols add a morning fasted injection to capture a second daily pulse window. A third midday injection is used in more aggressive research protocols but requires strict fasting around that window.
Reconstitution note: Both peptides are typically reconstituted with bacteriostatic water. A pre-blended 5mg/5mg vial simplifies dosing. Store reconstituted peptide refrigerated and use within 28–30 days.
The CJC/Ipa stack has a notably cleaner side-effect profile than older GH secretagogue combinations. Ipamorelin's selectivity is the key reason.
What Ipamorelin avoids (unlike older GHRPs): Significant cortisol elevation, prolactin spikes, and pronounced hunger/appetite dysregulation — all common issues with GHRP-6 and GHRP-2.
All content on this page is for educational and research purposes only. CJC-1295 and Ipamorelin are research compounds not approved for human use. This is not medical advice. Consult a qualified healthcare provider before use.
COA-verified vendor pricing with promo codes, full protocol reference, and dosage calculator.
Full Reference Guide → Dosage Calculator